VRDN – viridian therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Viridian Therapeutics (VRDN) had its "sell (d-)" rating reaffirmed by Weiss Ratings.
Kopp Family Office Trims $3.5 Million Worth of Viridian Therapeutics Stake -- What Investors Should Know [Yahoo! Finance]
Viridian Therapeutics (VRDN) had its price target lowered by Truist Financial Corporation from $36.00 to $33.00. They now have a "buy" rating on the stock.
Analysts Have Just Cut Their Viridian Therapeutics, Inc. (NASDAQ:VRDN) Revenue Estimates By 20% [Yahoo! Finance]
Viridian Therapeutics price target lowered to $36 from $40 at Truist [Yahoo! Finance]
Form ARS Viridian Therapeutics, For: Dec 31
Form DEFA14A Viridian Therapeutics,
Form DEF 14A Viridian Therapeutics, For: Jun 02
Form 8-K Viridian Therapeutics, For: Mar 30
Form SCHEDULE 13G/A Viridian Therapeutics, Filed by: VANGUARD GROUP INC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.